// App-Quantinova.ai

Mo1191 : a Pilot Study of Optimal Screening for Latent Tuberculosis in Patients With Inflammatory Bowel Disease

Researchers

Presenter

  • Madhukar Pai

Principal Investigators

  • Matthew Strohl

  • Talat Bessissow

  • Alain Bitton

  • Ernest G. Seidman

  • Waqqas Afif

Medical Centers

  • Division of Epidemiology and Biostatistics, McGill University Health Centre, Montreal, QC, Canada

  • Gastroenterology, Mc Gill University Health Center, Montreal, Quebec, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory bowel disease

  • Ulcerative colitis

  • Crohn's disease

  • Tuberculosis

Biomarkers

  • N/A

Drug/Treatment

  • Interferon Gamma

  • Methotrexate

  • Interferon

  • Tuberculin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved